Novartis firm posted sales of €112m

Revenues at the main Ringaskiddy-based unit of pharma giant Novartis rose 3.5% to over €112.1m last year.

However, an increase in costs saw pre-tax profits at Novartis Ringaskiddy Ltd declining by 2%, to €16.7m.